The 20 Best T-Cell Lymphoma Doctors Near Me

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Richard Stone is a Hematologist Oncology specialist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Stone is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Stone is board certified in Hematology, Internal Medicine, and Medical Oncology.

Larisa Geskin is an Oncologist practicing medicine in New York, New York. Dr. Geskin is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome.

Kristie Blum is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 29 years. Dr. Blum is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Blum is board certified in American Board Of Internal Medicine, 2004.

Christiane Querfeld is a Dermatologist practicing medicine in Duarte, California. Dr. Querfeld is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.

Jacob Laubach is an Oncologist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Laubach is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Laubach is board certified in Hematology, Internal Medicine, and Medical Oncology.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Erba is board certified in American Board Of Internal Med, Hematology.

Sagar Lonial is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 33 years. Dr. Lonial is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Aplastic Anemia, and Bone Marrow Transplant. Dr. Lonial is board certified in American Board Of Internal Medicine, 2000.

Jonathan Kaufman is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 27 years. Dr. Kaufman is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Primary Amyloidosis, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kaufman is board certified in American Board Of Internal Medicine, 2005.

Craig Hofmeister is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 27 years. Dr. Hofmeister is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hofmeister is board certified in American Board Of Internal Medicine, 2005.

David Rizzieri is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Rizzieri is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Wei Wang is a Psychiatrist practicing medicine in Flemington, New Jersey. Dr. Wang is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 84 other conditions, according to our data. Her clinical expertise encompasses Gallbladder Disease, Ocular Hypertension (OHT), Dementia, Endoscopy, and Bone Marrow Aspiration. Dr. Wang is currently accepting new patients.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Selina Luger is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Luger is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Luger is board certified in Hematology, 1994. Dr. Luger is currently accepting new patients.

Youn-hee Kim is a Dermatologist practicing medicine in Palo Alto, California. Dr. Kim is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Sezary Syndrome.

David Vesole is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Vesole is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Vesole is board certified in American Board Of Internal Medicine.

Auris Huen is a Dermatologist practicing medicine in Cary, North Carolina. Dr. Huen is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Lymphomatoid Papulosis, and Thymectomy.

Michi Shinohara is a Dermatologist practicing medicine in Seattle, Washington. Dr. Shinohara is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Michael Girardi is a Dermatologist practicing medicine in New Haven, Connecticut. Dr. Girardi is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.